Loading…
Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy
Application of nanoparticles has recently promising results for water insoluble agents like curcumin. In this study, we synthesized polymeric nanoparticle-curcumin (PNPC) and then showed its efficiency, drug loading, stability, and safety. Therapeutic effects of PNPC were also assessed on two cell l...
Saved in:
Published in: | BioMed research international 2015-01, Vol.2015 (2015), p.1-14 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453 |
---|---|
cites | cdi_FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453 |
container_end_page | 14 |
container_issue | 2015 |
container_start_page | 1 |
container_title | BioMed research international |
container_volume | 2015 |
creator | Khodayari, Hamid Mohagheghi, Mohammad Ali Khodayari, Saeed Rezaei, Arezou Khaniki, Mahmood Erfani-Moghadam, Vahid Ardestani, Sussan K. Najafi, Farhood Sadeghizadeh, Majid Alizadeh, Ali Mohammad Zamani, Mina |
description | Application of nanoparticles has recently promising results for water insoluble agents like curcumin. In this study, we synthesized polymeric nanoparticle-curcumin (PNPC) and then showed its efficiency, drug loading, stability, and safety. Therapeutic effects of PNPC were also assessed on two cell lines and in an animal model of breast cancer. PNPC remarkably suppressed mammary and hepatocellular carcinoma cells proliferation ( P < 0.05 ). Under the dosing procedure, PNPC was safe at 31.25 mg/kg and lower doses. Higher doses demonstrated minimal hepatocellular and renal toxicity in paraclinical and histopathological examinations. Tumor take rate in PNPC-treated group was 37.5% compared with 87.5% in control ( P < 0.05 ). Average tumor size and weight were significantly lower in PNPC group than control ( P < 0.05 ). PNPC increased proapoptotic Bax protein expression ( P < 0.05 ). Antiapoptotic Bcl-2 protein expression, however, was lower in PNPC-treated animals than the control ones ( P < 0.05 ). In addition, proliferative and angiogenic parameters were statistically decreased in PNPC-treated animals ( P < 0.05 ). These results highlight the suppressing role for PNPC in in vitro and in vivo tumor growth models. Our findings provide credible evidence for superior biocompatibility of the polymeric nanocarrier in pharmacological arena together with an excellent tumor-suppressing response. |
doi_str_mv | 10.1155/2015/824746 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4352453</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A458163466</galeid><sourcerecordid>A458163466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhSNERau2J-4oEhdUtG3G9nidC1IVChQVcSlny_FOui6JHewNaP89jrYshVMtS2PZ3zx53iuKl1CdAyBesArwQjGxFPJZccQ4iIUEAc_3Z84Pi9OU7qu8FMiqli-KQ4bLmrNKHRWfr7w1Y5p6s3HBl6ErmynaaXC-zPu9a_tgv5dNGEO_HSiWX5ylvqdUdiGWjfE2392uKZpxe1IcdKZPdPpQj4tvH65um0-Lm68fr5vLm4VFpjaLDmtGbKVsa2sULSoizmsCJRHrXGVFrQKmWhBKcFi1LQfMOBPMmk4gPy7e7XTHqR1oZclvoun1GN1g4lYH4_S_L96t9V34qQVHlvuzwJsHgRh-TJQ2enBpHst4ClPSIJeSo8oGPQGVCAyFWGb09X_ofZiiz07MFHBgAthf6s70pJ3vQv6inUX1pcAcEBdSZurtjrIxpBSp208HlZ5z13Puepd7pl89NmTP_kk5A2c7YO38yvxyT1OjjFBnHsEolQL-G9XPu74</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1661312412</pqid></control><display><type>article</type><title>Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley-Blackwell Titles (Open access)</source><creator>Khodayari, Hamid ; Mohagheghi, Mohammad Ali ; Khodayari, Saeed ; Rezaei, Arezou ; Khaniki, Mahmood ; Erfani-Moghadam, Vahid ; Ardestani, Sussan K. ; Najafi, Farhood ; Sadeghizadeh, Majid ; Alizadeh, Ali Mohammad ; Zamani, Mina</creator><contributor>Cavalcanti, Bruno C.</contributor><creatorcontrib>Khodayari, Hamid ; Mohagheghi, Mohammad Ali ; Khodayari, Saeed ; Rezaei, Arezou ; Khaniki, Mahmood ; Erfani-Moghadam, Vahid ; Ardestani, Sussan K. ; Najafi, Farhood ; Sadeghizadeh, Majid ; Alizadeh, Ali Mohammad ; Zamani, Mina ; Cavalcanti, Bruno C.</creatorcontrib><description><![CDATA[Application of nanoparticles has recently promising results for water insoluble agents like curcumin. In this study, we synthesized polymeric nanoparticle-curcumin (PNPC) and then showed its efficiency, drug loading, stability, and safety. Therapeutic effects of PNPC were also assessed on two cell lines and in an animal model of breast cancer. PNPC remarkably suppressed mammary and hepatocellular carcinoma cells proliferation ( P < 0.05 ). Under the dosing procedure, PNPC was safe at 31.25 mg/kg and lower doses. Higher doses demonstrated minimal hepatocellular and renal toxicity in paraclinical and histopathological examinations. Tumor take rate in PNPC-treated group was 37.5% compared with 87.5% in control ( P < 0.05 ). Average tumor size and weight were significantly lower in PNPC group than control ( P < 0.05 ). PNPC increased proapoptotic Bax protein expression ( P < 0.05 ). Antiapoptotic Bcl-2 protein expression, however, was lower in PNPC-treated animals than the control ones ( P < 0.05 ). In addition, proliferative and angiogenic parameters were statistically decreased in PNPC-treated animals ( P < 0.05 ). These results highlight the suppressing role for PNPC in in vitro and in vivo tumor growth models. Our findings provide credible evidence for superior biocompatibility of the polymeric nanocarrier in pharmacological arena together with an excellent tumor-suppressing response.]]></description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2015/824746</identifier><identifier>PMID: 25793208</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Animals ; Antineoplastic Agents - administration & dosage ; Apoptosis - drug effects ; Block copolymers ; Breast cancer ; Breast Neoplasms - drug therapy ; Cancer ; Carcinoma, Hepatocellular - drug therapy ; Care and treatment ; Cell Line ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Curcumin - administration & dosage ; Drug Carriers - administration & dosage ; Drug delivery systems ; Drug Stability ; Female ; Humans ; Liver Neoplasms - drug therapy ; Medical research ; Mice ; Mice, Inbred BALB C ; Micelles ; Nanoparticles - administration & dosage ; Polyethylene glycol ; Polymers - administration & dosage ; Production processes ; Turmeric</subject><ispartof>BioMed research international, 2015-01, Vol.2015 (2015), p.1-14</ispartof><rights>Copyright © 2015 Ali Mohammad Alizadeh et al.</rights><rights>COPYRIGHT 2015 John Wiley & Sons, Inc.</rights><rights>Copyright © 2015 Ali Mohammad Alizadeh et al. Ali Mohammad Alizadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2015 Ali Mohammad Alizadeh et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453</citedby><cites>FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1661312412/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1661312412?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25751,27922,27923,37010,37011,44588,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25793208$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Cavalcanti, Bruno C.</contributor><creatorcontrib>Khodayari, Hamid</creatorcontrib><creatorcontrib>Mohagheghi, Mohammad Ali</creatorcontrib><creatorcontrib>Khodayari, Saeed</creatorcontrib><creatorcontrib>Rezaei, Arezou</creatorcontrib><creatorcontrib>Khaniki, Mahmood</creatorcontrib><creatorcontrib>Erfani-Moghadam, Vahid</creatorcontrib><creatorcontrib>Ardestani, Sussan K.</creatorcontrib><creatorcontrib>Najafi, Farhood</creatorcontrib><creatorcontrib>Sadeghizadeh, Majid</creatorcontrib><creatorcontrib>Alizadeh, Ali Mohammad</creatorcontrib><creatorcontrib>Zamani, Mina</creatorcontrib><title>Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description><![CDATA[Application of nanoparticles has recently promising results for water insoluble agents like curcumin. In this study, we synthesized polymeric nanoparticle-curcumin (PNPC) and then showed its efficiency, drug loading, stability, and safety. Therapeutic effects of PNPC were also assessed on two cell lines and in an animal model of breast cancer. PNPC remarkably suppressed mammary and hepatocellular carcinoma cells proliferation ( P < 0.05 ). Under the dosing procedure, PNPC was safe at 31.25 mg/kg and lower doses. Higher doses demonstrated minimal hepatocellular and renal toxicity in paraclinical and histopathological examinations. Tumor take rate in PNPC-treated group was 37.5% compared with 87.5% in control ( P < 0.05 ). Average tumor size and weight were significantly lower in PNPC group than control ( P < 0.05 ). PNPC increased proapoptotic Bax protein expression ( P < 0.05 ). Antiapoptotic Bcl-2 protein expression, however, was lower in PNPC-treated animals than the control ones ( P < 0.05 ). In addition, proliferative and angiogenic parameters were statistically decreased in PNPC-treated animals ( P < 0.05 ). These results highlight the suppressing role for PNPC in in vitro and in vivo tumor growth models. Our findings provide credible evidence for superior biocompatibility of the polymeric nanocarrier in pharmacological arena together with an excellent tumor-suppressing response.]]></description><subject>Animals</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Apoptosis - drug effects</subject><subject>Block copolymers</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Cancer</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Care and treatment</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Curcumin - administration & dosage</subject><subject>Drug Carriers - administration & dosage</subject><subject>Drug delivery systems</subject><subject>Drug Stability</subject><subject>Female</subject><subject>Humans</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Medical research</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Micelles</subject><subject>Nanoparticles - administration & dosage</subject><subject>Polyethylene glycol</subject><subject>Polymers - administration & dosage</subject><subject>Production processes</subject><subject>Turmeric</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkUFv1DAQhSNERau2J-4oEhdUtG3G9nidC1IVChQVcSlny_FOui6JHewNaP89jrYshVMtS2PZ3zx53iuKl1CdAyBesArwQjGxFPJZccQ4iIUEAc_3Z84Pi9OU7qu8FMiqli-KQ4bLmrNKHRWfr7w1Y5p6s3HBl6ErmynaaXC-zPu9a_tgv5dNGEO_HSiWX5ylvqdUdiGWjfE2392uKZpxe1IcdKZPdPpQj4tvH65um0-Lm68fr5vLm4VFpjaLDmtGbKVsa2sULSoizmsCJRHrXGVFrQKmWhBKcFi1LQfMOBPMmk4gPy7e7XTHqR1oZclvoun1GN1g4lYH4_S_L96t9V34qQVHlvuzwJsHgRh-TJQ2enBpHst4ClPSIJeSo8oGPQGVCAyFWGb09X_ofZiiz07MFHBgAthf6s70pJ3vQv6inUX1pcAcEBdSZurtjrIxpBSp208HlZ5z13Puepd7pl89NmTP_kk5A2c7YO38yvxyT1OjjFBnHsEolQL-G9XPu74</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Khodayari, Hamid</creator><creator>Mohagheghi, Mohammad Ali</creator><creator>Khodayari, Saeed</creator><creator>Rezaei, Arezou</creator><creator>Khaniki, Mahmood</creator><creator>Erfani-Moghadam, Vahid</creator><creator>Ardestani, Sussan K.</creator><creator>Najafi, Farhood</creator><creator>Sadeghizadeh, Majid</creator><creator>Alizadeh, Ali Mohammad</creator><creator>Zamani, Mina</creator><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy</title><author>Khodayari, Hamid ; Mohagheghi, Mohammad Ali ; Khodayari, Saeed ; Rezaei, Arezou ; Khaniki, Mahmood ; Erfani-Moghadam, Vahid ; Ardestani, Sussan K. ; Najafi, Farhood ; Sadeghizadeh, Majid ; Alizadeh, Ali Mohammad ; Zamani, Mina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Apoptosis - drug effects</topic><topic>Block copolymers</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Cancer</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Care and treatment</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Curcumin - administration & dosage</topic><topic>Drug Carriers - administration & dosage</topic><topic>Drug delivery systems</topic><topic>Drug Stability</topic><topic>Female</topic><topic>Humans</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Medical research</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Micelles</topic><topic>Nanoparticles - administration & dosage</topic><topic>Polyethylene glycol</topic><topic>Polymers - administration & dosage</topic><topic>Production processes</topic><topic>Turmeric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khodayari, Hamid</creatorcontrib><creatorcontrib>Mohagheghi, Mohammad Ali</creatorcontrib><creatorcontrib>Khodayari, Saeed</creatorcontrib><creatorcontrib>Rezaei, Arezou</creatorcontrib><creatorcontrib>Khaniki, Mahmood</creatorcontrib><creatorcontrib>Erfani-Moghadam, Vahid</creatorcontrib><creatorcontrib>Ardestani, Sussan K.</creatorcontrib><creatorcontrib>Najafi, Farhood</creatorcontrib><creatorcontrib>Sadeghizadeh, Majid</creatorcontrib><creatorcontrib>Alizadeh, Ali Mohammad</creatorcontrib><creatorcontrib>Zamani, Mina</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khodayari, Hamid</au><au>Mohagheghi, Mohammad Ali</au><au>Khodayari, Saeed</au><au>Rezaei, Arezou</au><au>Khaniki, Mahmood</au><au>Erfani-Moghadam, Vahid</au><au>Ardestani, Sussan K.</au><au>Najafi, Farhood</au><au>Sadeghizadeh, Majid</au><au>Alizadeh, Ali Mohammad</au><au>Zamani, Mina</au><au>Cavalcanti, Bruno C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>2015</volume><issue>2015</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract><![CDATA[Application of nanoparticles has recently promising results for water insoluble agents like curcumin. In this study, we synthesized polymeric nanoparticle-curcumin (PNPC) and then showed its efficiency, drug loading, stability, and safety. Therapeutic effects of PNPC were also assessed on two cell lines and in an animal model of breast cancer. PNPC remarkably suppressed mammary and hepatocellular carcinoma cells proliferation ( P < 0.05 ). Under the dosing procedure, PNPC was safe at 31.25 mg/kg and lower doses. Higher doses demonstrated minimal hepatocellular and renal toxicity in paraclinical and histopathological examinations. Tumor take rate in PNPC-treated group was 37.5% compared with 87.5% in control ( P < 0.05 ). Average tumor size and weight were significantly lower in PNPC group than control ( P < 0.05 ). PNPC increased proapoptotic Bax protein expression ( P < 0.05 ). Antiapoptotic Bcl-2 protein expression, however, was lower in PNPC-treated animals than the control ones ( P < 0.05 ). In addition, proliferative and angiogenic parameters were statistically decreased in PNPC-treated animals ( P < 0.05 ). These results highlight the suppressing role for PNPC in in vitro and in vivo tumor growth models. Our findings provide credible evidence for superior biocompatibility of the polymeric nanocarrier in pharmacological arena together with an excellent tumor-suppressing response.]]></abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>25793208</pmid><doi>10.1155/2015/824746</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2314-6133 |
ispartof | BioMed research international, 2015-01, Vol.2015 (2015), p.1-14 |
issn | 2314-6133 2314-6141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4352453 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley-Blackwell Titles (Open access) |
subjects | Animals Antineoplastic Agents - administration & dosage Apoptosis - drug effects Block copolymers Breast cancer Breast Neoplasms - drug therapy Cancer Carcinoma, Hepatocellular - drug therapy Care and treatment Cell Line Cell Line, Tumor Cell Proliferation - drug effects Curcumin - administration & dosage Drug Carriers - administration & dosage Drug delivery systems Drug Stability Female Humans Liver Neoplasms - drug therapy Medical research Mice Mice, Inbred BALB C Micelles Nanoparticles - administration & dosage Polyethylene glycol Polymers - administration & dosage Production processes Turmeric |
title | Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A12%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Encapsulation%20of%20Curcumin%20in%20Diblock%20Copolymer%20Micelles%20for%20Cancer%20Therapy&rft.jtitle=BioMed%20research%20international&rft.au=Khodayari,%20Hamid&rft.date=2015-01-01&rft.volume=2015&rft.issue=2015&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2015/824746&rft_dat=%3Cgale_pubme%3EA458163466%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-f592e2d8cbc954b58ee339e1865599e160eb8128b148431dbb315d8c242caf453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1661312412&rft_id=info:pmid/25793208&rft_galeid=A458163466&rfr_iscdi=true |